Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum

Neurology

Volumn 47, Issue 1, 1996, Pages 219-224

  Herrero, M T ^a,c   Levy, R ^b   Ruberg, M ^b   Luquin, M R ^a   Villares, J ^b   Guillen, J ^a   Faucheux, B ^b   Javoy Agid, F ^b   Guridi, J ^a   Agid, Y ^b   Obeso, J A ^a   Hirsch, E C ^b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c UNIVERSITY OF MURCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE DECARBOXYLASE; LEVODOPA;

AGED; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DENERVATION; GLOBUS PALLIDUS; HUMAN; HUMAN TISSUE; NEUROTRANSMISSION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 8944242600     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.1.219     Document Type: Article

References (32)

1. Yahr MD. Parkinson's disease: the L-dopa era. In: Parkinson's disease from basic research to treatment. Adv Neurol 1993;60: 11-17.
2. Wichmann T, DeLong MR. Pathophysiology of parkinsonian motor abnormalities. In: Parkinson's disease from basic research to treatment. Adv Neurol 1993;60:53-61.
3. Herrero MT, Hirsch EC, Kastner A, et al. Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP? Neuroscience 1993;56: 499-511.
4. Bu DF, Erlander MG, Hitz BC, et al. Two human glutamate decarboxylase, 65-kDa GAD and 67-kDa GAD, are encoded by a single gene. Proc Natl Acad Sci USA 1992;89:2115-2119.
5. Fontaine B, Sassoon D, Buckingham M, Changeux JP. Detection of nicotinic acetylcholine receptor subunit by in situ hybridization at neuromuscular junction of 15-old-day chick striatal muscles. EMBO J 1988;7:603-609.
6. Chesselet MF, Weiss L, Wuenschell C, et al. Comparative distribution of RNAs for glutamic acid decarboxylase, tyrosine hydroxylase and tachykinins in the basal ganglia: an in situ hybridization study in the rodent brain. J Comp Neurol 1987; 262:125-140.
7. Herrero MT, Ruberg M, Hirsch EC, et al. In situ hybridization of GAD mRNA in monkey and human brain: quantification at both regional and cellular levels. Neurosci Lett 1993;157:57-61.
8. Bisconte JC, Fulcrand J, Marty R. Analyse radioautographique dans le système nerveux central par photométric et cartographie combinées. CR Soc Biol 1968;162:2178.
9. Javoy-Agid F, Hirsch EC, Dumas S, et al. Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study. Neuroscience 1990;38:245-253.
10. Strada O, Vyas S, Hirsch EC, et al. Decreased choline acetyl-transferase mRNA expression in the nucleus basalis in Alzheimer disease: an in situ hybridization study. Proc Natl Acad Sci USA 1992;89:1295-1299.
11. Albers RW, Brady RO. The distribution of glutamic decarboxylase in the nervous system of the rhesus monkey. J Biol Chem 1959;234:926-928.
12. Chalmers A, McGeer EG, Wickson V, McGeer PL. Distribution of glutamic acid decarboxylase in the brains of various mammalian species. Comp Gen Pharmacol 1970;1:385-390.
13. McGeer PL, McGeer EG. Enzymes associated with the metabolism of catecholamines, acetylcholine and GABA in human controls and patients with Parkinson's disease and Huntington's chorea. J Neurochem 1976;26:65-76.
14. Mackay AVP, Davis P, Dawar AJ, Yates CM. Regional distribution of enzymes associated with neurotransmission by monoamines, acetylcholine and GABA in the human brain. J Neurochem 1978;30:827-839.
15. Monfort JC, Javoy-Agid F, Hauw JJ, et al. Brain glutamate decarboxylase in Parkinson's disease with particular reference to premortem severity index. Brain 1985;108:301-313.
16. Wood TL, Franz GD, Menkez JH, Tobin AJ. Regional distribution of messenger RNAs in postmortem human brain. Neurosci Res 1986;16:311-324.
17. r 67,000) and its messenger RNA in basal ganglia and cerebral cortex after ischemic cortical lesions in rats. Exp Neurol 1993;119:291-301.
18. Rinne UK, Laaksonen H, Riekkienen, Sonninen V. Brain glutamic acid decarboxylase activity in Parkinson's disease. Eur Neurol 1974;12:13-19.
19. 67 mRNA. Eur J Neurosci 1995;7:1199-1209.
20. Martin DL, Rimvall K. Regulation of gamma-aminobutyric acid synthesis in the brain. J Neurochem 1993;60:395-407.
21. Gale K, Casu M. Dynamic utilization of GABA in the substantia nigra: regulation by dopamine and GABA in the striatum and its clinical and behavioural implications. Mol Cell Biochem 1981;39:369-405.
22. Bara H, Lassman H, Hornykiewicz O. Behavioural and neurochemical changes 6 months after kainic acid. Soc Neurosci Abstr 1988;14:472.
23. Marksteiner J, Sperk G. Concomitant increase of somatostatin, neuropeptide Y and glutamate decarboxylase in frontal cortex of rats with decreased seizure threshold. Neuroscience 1988;26:379-385.
24. Linderfors N, Brene S, Persson H. Increased expression of glutamic acid decarboxylase in rat substantia nigra after ibotenic acid lesion in the caudate-putamen. Mol Brain Res 1990; 7:207-212.
25. 3H]flunitrazepam autoradiography. Brain Res 1990;531:95-104.
26. Alexander GE, Crutcher MD. Functional architecture of the basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 1990;13:266-271.
27. Gerfen CR, Thomas ME, Lawrence CM, et al. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 1990;250:1429-1432.
28. Filion M, Tremblay L. Spontaneous activity of globus pallidus neurons in monkeys with MPTP induced parkinsonism. Brain Res 1991;547:142-151.
29. Guridi J, Luquin MR, Herrero MT, Obeso JA. The subthalamic nucleus: a possible target for stereotaxic surgery in Parkinson's disease. Mov Disord 1993;8:421-429.
30. Guridi J, Herrero MT, Ruberg M, et al. Decreased GAD mRNA expression in internal pallidum and substantia nigra pars reticulata after subthalamotomy in MPTP-treated monkeys. Soc Neurosci Abstr 1993;19:133.
31. Marconi R, Lefebvre-Caparros D, Bonnet AM, et al. Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology. Mov Disord 1994;9:2-12.
32. Page RD, Sambrook MA, Crossman AR. Thalamotomy for the alleviation of levodopa-induced dyskinesia: experimental studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated parkinsonian monkey. Neuroscience 1993;55:147-165.